Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% Eye Drops for Dry Eye in Sjogren Syndrome
NCT01850979Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2010
- Primary completion
- Nov 2011
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Sjögren syndrome and dry eye syndrome (DED) comparing Tacrolimus 0.03% with Placebo (Olive Oil) (2 arms). Primary endpoint: Quantity of lacrimal film at 90 days. Started Feb 2010; status: completed.
02
Drugs
tacrolimus
03
Conditions
Sjögren syndromedry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01850979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01850979.